by CheckRare Staff | Jul 13, 2023
Thomas Hutson, DO, PharmD, FACP, Director of the Urologic Oncology Program at Baylor University Medical Center and the Sarah Cannon Research Institute at Texas Oncology I The US Oncology Network discusses the recent advances made in kidney cancer treatment. This...
by CheckRare Staff | Jul 6, 2023
Jill Kiernan explains Tatton Brown Rahman Syndrome (TBRS). Jill is the executive director of the TBRS Community, a patient advocacy group committed to bringing together families, clinicians, and researchers interested in this rare disease. TBRS is a rare...
by CheckRare Staff | Jun 27, 2023
Milan Radovich, Ph.D., Chief Scientific Officer at Caris Life Sciences, summarizes the company’s comprehensive clinico-genomic database being used to advance targeted therapy for various cancer types. As noted by Dr. Radovich, Caris performed whole...
by CheckRare Staff | Jun 26, 2023
Chadi Nabhan, MD, of Caris Life Sciences, summarizes the Caris Precision Oncology Alliance and some of the abstracts the alliance presented at ASCO 2023. The Precision Oncology Alliance includes partnerships with 83 cancer centers and academic...
by CheckRare Staff | Jun 23, 2023
Jordi Duran, PhD, Associate Professor at Institut Químic de Sarrià in Barcelona, and Niki Markou, parent of a child with Lafora disease, discuss the symptoms and pathophysiology of Lafora Disease. Lafora disease is a rare neurodegenerative condition that...
